Anisomycin induces apoptosis in cancers by a diversified mechanism, which can induce apoptosis in a variety of cancers, including kidney cancer, breast cancer and human glioma, by regulating the bcl-2, C-flip (L) and McL-1 pathways 56. Here, MCL1 is linked to breast carcinoma.